MizzouForward Keynote – Nanomedicine: New Frontier in Uterine Disease Treatment

November 28th | 3:30pm – 4:30pm

Acuff Auditorium (MA217) – School of Medicine

Join us for “Nanomedicine: New Frontier in Uterine Disease Treatment" a keynote presentation by School of Medicine - Obstetrics and Gynecology, MizzouForward faculty candidate, Dr. Taeho Kim. Dr. Kim will present on his research for approximately 40-minutes with a 20-minute question and answer session to follow.

Dr. Taeho Kim is an Assistant Professor at the Department of Biomedical Engineering (BME), Michigan State University (MSU). Dr. Kim completed his Ph.D. in 2013 from Seoul National University, including two years of visiting research at Johns Hopkins Medicine. After finishing his postdoctoral training at UCSD, Dr. Kim joined as a faculty member (tenure-line) at MSU BME in Fall 2018 and successfully established his independent research program in molecular imaging and nanomedicine. Dr. Kim has a productive track record with 35 publications with more than 5,700 citations (h-index of 26), and he recently secured a 5-year R01 grant award (1R01HD108895-01) from NIH.

Functional inorganic nanoparticles feature interesting optical, magnetic, plasmonic, and catalytic properties as well as effective (bio)molecular recognition. Nanoparticles with imaging capabilities can be used to detect disease initiation and progression and to track therapeutic interventions. Upon loading therapeutic payloads into the nanoscale matrix (‘theranostics’), the nanoparticles can improve the treatment specificity of drug therapy. Eventually, nanotechnology can offer the conventional treatment regime to be less invasive and more precise, potentially leading to shorter hospital stays and fewer repeat procedures. In this lecture, Dr. Kim will present the recent efforts in his lab to develop novel nanotheranostic agents for cancer treatment or for the management of inflammation in tandem with photoacoustic imaging. He will also emphasize the nanomedicine approach for novel diagnostic and therapeutic in uterine disease, specifically for endometriosis.

You can access Dr. Kim’s CV via OneDrive here:

 Kim, Taeho_CV_11.22.pdf  (University log in required to access)

After the keynote, please provide candidate feedback with our brief survey.